AZD3839

AZD3839

Biochem/physiol Actions

AZD3839 is a potent and selective BACE1 inhibitor (Ki = 26.1 nM/BACE1, 372.4 nM/BACE2, >25 µM/Cathepsin D by cell-free TR-FRET; hERG IC50 = 4.8 µM) that effectively suppresses cellular BACE1 activity in neuron cultures (sAPPβ release IC50 = 16.7 nM/SH-SY5Y; Aβ40 release IC50 = 4.8 nM/SH-SY5Y AAP695wt, 32.2 nM/N2A, 24.8 nM/guinea pig cortical neurons, 51 nM/murine cortical neurons) and exhibits in vivo Aβ40-, Aβ42-, sAPPβ-reducing efficacy (80 & 160 µmol/kg mouse, p.o.; 100 & 200 µmol/kg guinea pigs, p.o., 2.5 & 20 µmol/kg cynomolgus monkeys, i.v.) with good pharmacokinetic properties and oral availability.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3576378 AZD3839 white to beige SIGMA-ALDRICH −20°C DMSO: 2 mg/mL, clear powder ≥98% (HPLC)
£501.43 (exc VAT) per 25MG
-
+
3576379 AZD3839 white to beige SIGMA-ALDRICH −20°C DMSO: 2 mg/mL, clear powder ≥98% (HPLC)
£124.10 (exc VAT) per 5MG
-
+